Sarah‐Jane Schramm

Author

Sarah‐Jane Schramm

Also Known As

Heather K. Schmidt, Jacqueline E. Schein, Markus B. Schilhabel, Matthias Schlesner, Sarah-Jane Schramm, Sarah‐Jane Schramm, Schramm, S, Thorsten Schlomm

Publications

14.2K

Citations

H-Index

Concepts

All Affiliations

Melanoma Institute Australia The University of Sydney Royal Prince Alfred Hospital Westmead Institute for Medical Research UNSW Sydney

About

Sarah‐Jane Schramm is an author at Melanoma Institute Australia specializing in pathology, medicine, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	273
2	Engineering	2	2	79
3	Biostatistics	1	1	10
4	Cell Biology	1	1	13
5	Immunology	1	1	184

Sarah‐Jane Schramm

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Pan-cancer analysis of whole genomes Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Nature	2020	3.1K
Comprehensive molecular characterization of mitochondrial genomes in human cancers Yuan Yuan, Young Seok Ju, Young-Wook Kim, Nature Genetics	2020	489
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns Wei Jiao, Gurnit Atwal, Paz Polak, Nature Communications	2020	230
BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma Graham J. Mann, Gulietta M. Pupo, Anna Campain, Journal of Investigative Dermatology Nras MutationOncologyBraf MutationMedicineMelanoma	2012	184
Divergent mutational processes distinguish hypoxic and normoxic tumours Vinayak Bhandari, Constance H. Li, Robert G. Bristow, Nature Communications	2020	141
Sex differences in oncogenic mutational processes Constance H. Li, Stephenie D. Prokopec, Ren Sun, Nature Communications	2020	122
Determination of prognosis in metastatic melanoma through integration of clinico‐pathologic, mutation, mRNA, microRNA, and protein information Kaushala S. Jayawardana, Sarah‐Jane Schramm, Lauren E. Haydu, International Journal of Cancer	2014	92
MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with <i>BRAF</i> mutation and patient prognosis Varsha Tembe, Sarah‐Jane Schramm, Mitchell Stark, Pigment Cell & Melanoma Research Mrna ExpressionEngineeringPathologyPatient PrognosisCancer Biology	2014	66
Network-based biomarkers enhance classical approaches to prognostic gene expression signatures Rebecca Barter, Sarah‐Jane Schramm, Graham J. Mann BMC Systems Biology	2014	28
Molecular interaction networks for the analysis of human disease: Utility, limitations, and considerations Sarah‐Jane Schramm, Vivek Jayaswal, Apurv Goel, PROTEOMICS	2013	15

Page 1